Login to Your Account

Hansa Medical eyes 2018 BLA in kidney transplant desensitization

By Cormac Sheridan
Staff Writer

Wednesday, August 2, 2017

DUBLIN – A certain DNA endonuclease from Streptococcus pyogenes, Cas9, has gained enormous prominence as part of the revolutionary CRISPR-Cas9 genome editing system, but Hansa Medical AB is making waves with a different enzyme from the same bug.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription